The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XLV.b

Eosinophilic pleural effusion

Publications

Alagha K, Tummino C, Sofalvi T, Chanez P

Iatrogenic eosinophilic pleural effusion.

European respiratory review : an official journal of the European Respiratory Society 2011 Jun;20;118-20 — 2011 Jun — 118-20

Lê-Quang B, Calmels P, Valayer-Chaléat E, Fayolle-Minon I, Gautheron V

Dantrolene and pleural effusion: case report and review of literature.

Spinal cord 2004 May;42;317-20 — 2004 May — 317-20

Felz MW, Haviland-Foley DJ

Eosinophilic pleural effusion due to dantrolene: resolution with steroid therapy.

Southern medical journal 2001 May;94;502-4 — 2001 May — 502-4

Dohen F, Montagne V, Lelieur E

[Dantrolene-induced pleurisy: a case report].

Revue de pneumologie clinique 2000 Sep;56;261-3 — 2000 Sep — 261-3

Mahoney JM, Bachtel MD

Pleural effusion associated with chronic dantrolene administration.

The Annals of pharmacotherapy 1994 May;28;587-9 — 1994 May — 587-9

Miller DH, Haas LF

Pneumonitis, pleural effusion and pericarditis following treatment with dantrolene.

Journal of neurology, neurosurgery, and psychiatry 1984 May;47;553-4 — 1984 May — 553-4

Petusevsky ML, Faling LJ, Rocklin RE, Snider GL, Merliss AD, Moses JM, Dorman SA

Pleuropericardial reaction to treatment with dantrolene.

JAMA 1979 Dec 21;242;2772-4 — 1979 Dec 21 — 2772-4